Craig B. Thompson insider trades

Open-market stock purchases and sales by Craig B. Thompson, Director at Charles River Laboratories International, Inc, from SEC Form 4 filings since May 28, 2010.

Recent trades

DateStockTradeValue
May 8, 2026CRL Charles River Laboratories International, IncBought (not open market)$255K
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026REGN Regeneron Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CRL Charles River Laboratories International, Inc: other filings, last May 8, 2026
  • REGN Regeneron Pharmaceuticals, Inc: other filings, last Jan 2, 2026
  • MRK Merck & Co, Inc: other filings, last May 25, 2018

Get free alerts when Craig B. Thompson files a new trade →